Gapping down
In reaction to earnings/guidance:
- GDRX -32.9% (also authorizes new $250 mln share repurchase program), SEER -19.4%, AMBA -17.7%, BIGC -17.6%, VRM -15.3%, HRTX -12.7%, LCID -12.5% (also signs agreements for a full production factory in Saudi Arabia), PUBM -11.9%, GRPN -11.1%, EHTH -9.9%, SE -8.6%, VLDR -8.4%, GOEV -7.7%, NVAX -7% (also shares Phase 3 data on NVX-CoV2373), FOUR -6.6%, TREX -6.4%, SUPN -6.1%, PGNY -6%, SDC -5.5%, ACAD -5.5%, ENDP -5.1%, ZM -3.3% (also authorizes new $1 bln share repurchase program), OKE -2.7%, KD -2.3%, RKLB -2%, FGEN -1.9%, HPQ -1.9%, SJM -1.4%, SBAC -1.1%
Other news:
- OZON -19% (comments on impact of U.S., EU and other sanctions on its operations )
- NTLA -6.9% (NLTA and REGN announce interim data from Phase 1 study of NTLA-2001)
- FOUR -4.8% (will acquire both Finaro and The Giving Block)
- AES -3.4% (files mixed securities shelf offering)
- XPEV -2.6% (delivered 6,225 Smart EVs in February 2022, representing a 180% increase yr/yr)
- NIO -2.4% (provides February 2022 delivery update )
- HBAN -2.3% (to acquire Capstone Partners)
- THC -1.7% (will no longer pursue a spinoff of its Conifer Health Solutions subsidiary; reaffirms guidance; will host call at 10 a.m. ET )
- TTE -1.6% (will no longer provide capital for new projects in Russia)
Analyst comments:
- IONS -3.2% (initiated with a Sell at Citigroup )
- HEAR -2.8% (downgraded to Neutral from Outperform at Wedbush)
- WIX -1.5% (downgraded to Neutral from Overweight at Atlantic Equities)
- CMCSA -1% (downgraded to Hold from Buy at Truist)